Author: healthylife7

Novo Nordisk stock is trading close to record territory, with investors focusing on how sustained demand for its obesity and diabetes drugs is feeding through into revenue and profit growth for the Danish pharmaceutical group (ISIN DK0062498333). According to the companys most recent quarterly report for Q1 2025, Novo Nordisk reported revenue of DKK 108.0…

Read More

Private weight-loss camps in China are attracting growing interest — not just from locals, but increasingly from overseas visitors as well. The trend comes as Beijing steps up efforts to tackle obesity, with more than half of Chinese adults now overweight or obese. Most participants stay at the camp for at least 28 days. Some…

Read More

For decades, obesity has posed one of the most formidable threats to public health. Individuals living with obesity are at heightened risk of myriad co-morbid conditions, ranging from cardiovascular disease and type 2 diabetes to certain cancers. Given the expansive health implications of obesity, its prevention and treatment are critical to improving population health outcomes.…

Read More